Literature DB >> 30268788

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Chyke A Doubeni1, Stacey A Fedewa2, Theodore R Levin3, Christopher D Jensen3, Chelsea Saia4, Alexis M Zebrowski5, Virginia P Quinn6, Katharine A Rendle4, Ann G Zauber7, Tracy A Becerra-Culqui6, Shivan J Mehta8, Robert H Fletcher9, Joanne Schottinger6, Douglas A Corley3.   

Abstract

BACKGROUND & AIMS: Colorectal cancer (CRC) deaths occur when patients do not receive screening or have inadequate follow-up of abnormal results or when the screening test fails. We have few data on the contribution of each to CRC-associated deaths or factors associated with these events.
METHODS: We performed a retrospective cohort study of patients in the Kaiser Permanente Northern and Southern California systems (55-90 years old) who died of CRC from 2006 through 2012 and had ≥5 years of enrollment before diagnosis. We compared data from patients with those from a matched cohort of cancer-free patients in the same system. Receipt, results, indications, and follow-up of CRC tests in the 10-year period before diagnosis were obtained from electronic databases and chart audits.
RESULTS: Of 1750 CRC deaths, 75.9% (n = 1328) occurred in patients who were not up to date in screening and 24.1% (n = 422) occurred in patients who were up to date. Failure to screen was associated with fewer visits to primary care physicians. Of 3486 cancer-free patients, 44.6% were up to date in their screening. Patients who were up to date in their screening had a lower risk of CRC death (odds ratio, 0.38; 95% confidence interval, 0.33-0.44). Failure to screen, or failure to screen at appropriate intervals, occurred in a 67.8% of patients who died of CRC vs 53.2% of cancer-free patients; failure to follow-up on abnormal results occurred in 8.1% of patients who died of CRC vs 2.2% of cancer-free patients. CRC death was associated with higher odds of failure to screen or failure to screen at appropriate intervals (odds ratio, 2.40; 95% confidence interval, 2.07-2.77) and failure to follow-up on abnormal results (odds ratio, 7.26; 95% confidence interval, 5.26-10.03).
CONCLUSIONS: Being up to date on screening substantially decreases the risk of CRC death. In 2 health care systems with high rates of screening, most people who died of CRC had failures in the screening process that could be rectified, such as failure to follow-up on abnormal findings; these significantly increased the risk for CRC death.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoma; Cancer Prevention; Colon Cancer; Early Detection

Mesh:

Year:  2018        PMID: 30268788      PMCID: PMC6309478          DOI: 10.1053/j.gastro.2018.09.040

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  49 in total

Review 1.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

2.  Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.

Authors:  Shivan J Mehta; Christopher D Jensen; Virginia P Quinn; Joanne E Schottinger; Ann G Zauber; Reinier Meester; Adeyinka O Laiyemo; Stacey Fedewa; Michael Goodman; Robert H Fletcher; Theodore R Levin; Douglas A Corley; Chyke A Doubeni
Journal:  J Gen Intern Med       Date:  2016-07-13       Impact factor: 5.128

3.  A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon
Journal:  Cancer       Date:  2017-07-28       Impact factor: 6.860

4.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

5.  Colorectal Cancer Health Disparities and the Role of US Law and Health Policy.

Authors:  Chyke A Doubeni; Douglas A Corley; Ann G Zauber
Journal:  Gastroenterology       Date:  2016-03-24       Impact factor: 22.682

6.  Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Authors:  Nadeem Baig; Ronald E Myers; Barbara J Turner; James Grana; Todd Rothermel; Neil Schlackman; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

7.  Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

Authors:  Stephen H Taplin; Laura Ichikawa; Marianne Ulcickas Yood; M Michele Manos; Ann M Geiger; Sheila Weinmann; Joyce Gilbert; Judy Mouchawar; Wendy A Leyden; Robin Altaras; Robert K Beverly; Deborah Casso; Emily Oakes Westbrook; Kimberly Bischoff; Jane G Zapka; William E Barlow
Journal:  J Natl Cancer Inst       Date:  2004-10-20       Impact factor: 13.506

8.  Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.

Authors:  Chyke A Doubeni; Sheila Weinmann; Kenneth Adams; Aruna Kamineni; Diana S M Buist; Arlene S Ash; Carolyn M Rutter; V Paul Doria-Rose; Douglas A Corley; Robert T Greenlee; Jessica Chubak; Andrew Williams; Aimee R Kroll-Desrosiers; Eric Johnson; Joseph Webster; Kathryn Richert-Boe; Theodore R Levin; Robert H Fletcher; Noel S Weiss
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

9.  Adenoma detection rate and risk of colorectal cancer and death.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jeffrey K Lee; Chyke A Doubeni; Ann G Zauber; Jolanda de Boer; Bruce H Fireman; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Theodore R Levin; Charles P Quesenberry
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

10.  Cancer screening test use - United States, 2013.

Authors:  Susan A Sabatino; Mary C White; Trevor D Thompson; Carrie N Klabunde
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more
  22 in total

1.  Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action.

Authors:  Chyke A Doubeni; John M Wilkinson; Neil Korsen; David E Midthun
Journal:  Ann Fam Med       Date:  2020-05       Impact factor: 5.166

2.  An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.

Authors:  Matthew A Goldshore; Shivan J Mehta; Woodrow Fletcher; George Tzanis; Chyke A Doubeni; E Carter Paulson
Journal:  Am J Prev Med       Date:  2020-07       Impact factor: 5.043

Review 3.  Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.

Authors:  John M Carethers; Chyke A Doubeni
Journal:  Gastroenterology       Date:  2019-11-01       Impact factor: 22.682

4.  Operationalizing a Rideshare Intervention for Colonoscopy Completion: Barriers, Facilitators, and Process Recommendations.

Authors:  Ari Bell-Brown; Lisa Chew; Bryan J Weiner; Lisa Strate; Bryan Balmadrid; Cara C Lewis; Peggy Hannon; John M Inadomi; Scott D Ramsey; Rachel B Issaka
Journal:  Front Health Serv       Date:  2022-01-17

5.  Yield of Surveillance Colonoscopy in Older Adults with a History of Polyps: A Systematic Review and Meta-Analysis.

Authors:  Gregory J Williams; Sage T Hellerstedt; Paige N Scudder; Audrey H Calderwood
Journal:  Dig Dis Sci       Date:  2021-08-18       Impact factor: 3.487

6.  Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.

Authors:  Rachel B Issaka; Ari Bell-Brown; Jason Kao; Cyndy Snyder; Dana L Atkins; Lisa D Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey
Journal:  Prev Med Rep       Date:  2022-05-18

7.  Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort.

Authors:  Jennifer L Schneider; Heather Spencer Feigelson; Virginia P Quinn; Carmit McMullen; Pamela A Pawloski; John D Powers; Andrew T Sterrett; David Arterburn; Douglas A Corley
Journal:  Perm J       Date:  2020

8.  Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing.

Authors:  Joshua A Roth; Theo deVos; Scott D Ramsey
Journal:  Am Health Drug Benefits       Date:  2019-09

Review 9.  Framework and Strategies to Eliminate Disparities in Colorectal Cancer Screening Outcomes.

Authors:  Chyke A Doubeni; Kevin Selby; Samir Gupta
Journal:  Annu Rev Med       Date:  2020-11-18       Impact factor: 13.739

10.  Trends in Early-onset vs Late-onset Colorectal Cancer Incidence by Race/Ethnicity in the United States Cancer Statistics Database.

Authors:  Steven H Chang; Nicolas Patel; Mengmeng Du; Peter S Liang
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-26       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.